Pan American League of Associations for Rheumatology recommendations for the management of axial spondyloarthritis

被引：23

作者：

Bautista-Molano, Wilson ^{[1
]}

Fernandez-Avila, Daniel G. ^{[2
]}

Brance, Maria Lorena ^{[3
]}

Pedretti, Maria Gabriela Avila

Burgos-Vargas, Ruben ^{[4
]}

Corbacho, Ines ^{[5
]}

Cosentino, Vanesa Laura ^{[6
]}

Coto, Jose Francisco Diaz ^{[7
]}

Ho, Enrique Giraldo ^{[8
]}

Resende, Gustavo Gomes ^{[9
]}

Gutierrez, Luis Arturo ^{[10
]}

Gutierrez, Marwin ^{[11
]}

Vodnizza, Sebastian Eduardo Ibanez ^{[12
]}

Jauregui, Edwin ^{[13
]}

Ocampo, Vanessa ^{[14
]}

Rivero, Daniel Ruben Palleiro ^{[15
]}

Palominos, Penelope Esther ^{[16
]}

Tena, Cesar Pacheco ^{[17
]}

Quiceno, Guillermo Andres ^{[18
]}

Saldarriaga-Rivera, Lina Maria ^{[19
]}

Sommerfleck, Fernando Andres ^{[20
]}

Sariego, Annelise Goecke ^{[21
]}

Barrezueta, Claudia Vera ^{[22
]}

Espinoza, Luis Enrique Vega ^{[23
]}

Hinojosa, Oscar Vega ^{[24
,25
]}

Citera, Gustavo ^{[26
]}

Lozada, Carlos ^{[27
]}

Sampaio-Barros, Percival D. ^{[28
]}

Schneeberger, Emilce ^{[26
]}

Soriano, Enrique R. ^{[29
]}

机构：

[1] Univ Mil Nueva Granada, Univ El Bosque, Hosp Univ Fdn St afe Bogota, Fac Med, Bogota, Colombia

[2] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Bogota, Colombia

[3] Rosario Natl Univ, Sch Med, Bone Biol Lab, Rosario, Argentina

[4] Hosp Gen Mexico City, Mexico City, Mexico

[5] Univ Republ UDELAR, Catedra Reumatol, Montevideo, Uruguay

[6] Hosp Dr JM Ramos Mejia, Buenos Aires, Argentina

[7] Hosp Mexico, CCSS, San Jose, Costa Rica

[8] Pacifica Salud Hosp Punta Pacifica, Clin All, Panama City, Panama

[9] Univ Fed Minas Gerais, Belo Horizonte, Brazil

[10] UMIR Internal Med & Rheumatol Unit, Caracas, Venezuela

[11] CERM, Ctr Excellence Rheumat & Musculoskeletal Dis, Mexico City, Mexico

[12] Univ Desarrollo, Fac Med, Clin Alemana Santiago, Santiago, Chile

[13] Gestor Reumatol Riesgo Fractura SA, Bogota, Colombia

[14] Univ Toronto, Rheumatol, Toronto, ON, Canada

[15] Univ Republica, Cathedra Rheumatol, Uruguayan Soc Rheumatol, Montevideo, Uruguay

[16] Hosp Clin Porto Alegre, Rheumatol Div, Porto Alegre, Brazil

[17] Univ Autonoma Chihuahua Invest & Biomed Chihuahua, Fac Med, Neurol, Chihuahua, Mexico

[18] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX USA

[19] Univ Tecnol Pereira, Hosp Univ San Jorge Pereira, Fac Med, Pereira, Risaralda, Colombia

[20] Sanat Julio Mendez, Buenos Aires, Argentina

[21] Hosp Clin Univ Chile, Santiago, Chile

[22] Univ Catolica Santiago Guayaquil, Guayaquil, Ecuador

[23] Univ Piura, Hosp Cent Fuerza Aerea, Fac Med, Lima, Peru

[24] Ctr Med Reumactr, Juliaca, Peru

[25] Hosp III Red Asistencial Essalud, Juliaca, Peru

[26] Inst Rehabil Psicofis, Buenos Aires, Argentina

[27] Univ Miami, Miller Sch Med, Div Rheumatol, Miami, FL USA

[28] Univ Sao Paulo, Fac Med, Rheumatol Div, Sao Paulo, Brazil

[29] Hosp Italiano Buenos Aires, Internal Med Serv & Univ Inst, Rheumatol Unit, Buenos Aires, Argentina

来源：

NATURE REVIEWS RHEUMATOLOGY | 2023年 / 19卷 / 11期

关键词：

NECROSIS-FACTOR INHIBITORS; ANKYLOSING-SPONDYLITIS PATIENTS; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; DOSE REDUCTION STRATEGY; BLIND CROSSOVER TRIAL; QUALITY-OF-LIFE; LONG-TERM; RADIOGRAPHIC PROGRESSION; ANTERIOR UVEITIS; EXERCISE PROGRAM;

D O I：

10.1038/s41584-023-01034-z

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Axial spondyloarthritis (axSpA) comprises a spectrum of chronic inflammatory manifestations affecting the axial skeleton and represents a challenge for diagnosis and treatment. Our objective was to generate a set of evidence-based recommendations for the management of axSpA for physicians, health professionals, rheumatologists and policy decision makers in Pan American League of Associations for Rheumatology (PANLAR) countries. Grading of Recommendations, Assessment, Development and Evaluation-ADOLOPMENT methodology was used to adapt existing recommendations after performing an independent systematic search and synthesis of the literature to update the evidence. A working group consisting of rheumatologists, epidemiologists and patient representatives from countries within the Americas prioritized 13 topics relevant to the context of these countries for the management of axSpA. This Evidence-Based Guideline article reports 13 recommendations addressing therapeutic targets, the use of NSAIDs and glucocorticoids, treatment with DMARDs (including conventional synthetic, biologic and targeted synthetic DMARDs), therapeutic failure, optimization of the use of biologic DMARDs, the use of drugs for extra-musculoskeletal manifestations of axSpA, non-pharmacological interventions and the follow-up of patients with axSpA.

引用

页码：724 / 737

页数：14

共 171 条

[1] Drug levels, immunogenicity and assessment of active sacroiliitis in patients with axial spondyloarthritis under biologic tapering strategy [J].

Almirall, Miriam ;

Gimeno, Ramon ;

Carlos Salman-Monte, Tarek ;

Iniesta, Silvia ;

Pilar Lisbona, Maria ;

Maymo, Joan .

RHEUMATOLOGY INTERNATIONAL, 2016, 36 (04) :575-578

[2] Effect of Pilates training on people with ankylosing spondylitis [J].

Altan, L. ;

Korkmaz, N. ;

Dizdar, M. ;

Yurtkuran, M. .

RHEUMATOLOGY INTERNATIONAL, 2012, 32 (07) :2093-2099

[3]

Altan L, 2001, SCAND J RHEUMATOL, V30, P255

[4] COMPARATIVE-STUDY OF BUTACOTE AND NAPROSYN IN ANKYLOSING-SPONDYLITIS [J].

ANSELL, BM ;

MAJOR, G ;

LIYANAGE, SP ;

GUMPEL, JM ;

SEIFERT, MH ;

MATHEWS, JA ;

ENGLER, C .

ANNALS OF THE RHEUMATIC DISEASES, 1978, 37 (05) :436-439

[5]

Arends S, 2015, CLIN EXP RHEUMATOL, V33, P174

[6]

BACON P A, 1990, European Journal of Rheumatology and Inflammation, V10, P22

[7] A randomized, clinical trial to assess the relative efficacy and tolerability of two doses of etoricoxib versus naproxen in patients with ankylosing spondylitis [J].

Balazcs, Eva ;

Sieper, Joachim ;

Bickham, Kara ;

Mehta, Anish ;

Frontera, Nancy ;

Stryszak, Paul ;

Popmihajlov, Zoran ;

Peloso, Paul M. .

BMC MUSCULOSKELETAL DISORDERS, 2016, 17 :1-12

[8] Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab [J].

Baraliakos, X ;

Listing, J ;

Brandt, J ;

Rudwaleit, M ;

Sieper, J ;

Braun, J .

ARTHRITIS RESEARCH & THERAPY, 2005, 7 (03) :R439-R444

[9]

Baraliakos X, Arthritis Rheumatol, V74

[10]

Barkhuizen A, 2006, J RHEUMATOL, V33, P1805

← 1 2 3 4 5 6 7 8 9 10 →